Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

Neurology

Volumn 63, Issue 3, 2004, Pages 535-537

  De Wit, M C Y ^a   De Bruin, H G ^a   Eijkenboom, W ^a   Sillevis Smitt, P A E ^a   Van Den Bent, M J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL TRIAL; CONVALESCENCE; DIAGNOSTIC IMAGING; DISEASE COURSE; GLIOBLASTOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR GROWTH; TUMOR RECURRENCE;

EID: 3543148964     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000133398.11870.9A     Document Type: Article

References (10)

1. Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000;217:377-384.
2. Norris AM, Carrington BM, Slevin NJ. Late radiation change in the CNS: MR imaging following gadolinium enhancement. Clin Radiol 1997;52:356-362.
3. Bakardjiev AI, Barnes PD, Goumnerova LC, et al. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer 1996;78:864-873.
4. Hoffman WF, Levin VA, Wilson CB. Evaluation of malignant glioma patients during the postirradiation period. J Neurosurg 1979;50:624-628.
5. Cascino TL, Kimmel DW, Dinapoli RP, O'Neill BP, Scheithauer B. Report of four cases with a resolving syndrome which otherwise simulates recurrent brain tumor. Neurology 1988;38(suppl 1):306. Abstract.
6. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
7. Yung WKA, Albright RE, Olson J, et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000;83:588-593.
8. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1-10.
9. Gaspar LE, Fisher BJ, Macdonald DR, et al. Malignant glioma - timing of response to radiation therapy. Int J Radiation Oncol Biol Phys 1993;25:877-879.
10. Jennings MT. Neurological complications of radiotherapy. In: Wiley RG, ed. Neurological complications of cancer. New York: Marcel Dekker, 1995;219-240.